Not manycompaniesthis size with2 late stageassetsWe intendto submita BLA in2H 2022Mino-WrapThe name Citiuscomes from theOlympic motto"Citius,AltiusFortius"An actualiMSCupdateMyron Holubiakand I founded aprivatecompany in2013There are noFDAapproveddrugs to treathemorrhoidsOnly biotechwith 2 Myron'son theleadershipteamOur Halo-Lido trial willhave finalpatient byend of 2022I/ONTAK'spotentialmarket is>$300mHemorrhoidsis a $2BmarketI'm ashareholdermyselfI/ONTAKwas thebest deal Iever madeWe expect tofinish theMino-Loktrial this yearI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.We willhaveexclusivityWe haveenough cashto go wellinto 2023We will openupinternationalsites forMino-Lok trialI/ONTAKis our leadassetI won't diluteshareholdersWe had aphase 2btrial with100%efficacyInsidersinvested$26.5mMino-Lokpotentialmarket>$1BMino-Lokis our leadassetNot manycompaniesthis size with2 late stageassetsWe intendto submita BLA in2H 2022Mino-WrapThe name Citiuscomes from theOlympic motto"Citius,AltiusFortius"An actualiMSCupdateMyron Holubiakand I founded aprivatecompany in2013There are noFDAapproveddrugs to treathemorrhoidsOnly biotechwith 2 Myron'son theleadershipteamOur Halo-Lido trial willhave finalpatient byend of 2022I/ONTAK'spotentialmarket is>$300mHemorrhoidsis a $2BmarketI'm ashareholdermyselfI/ONTAKwas thebest deal Iever madeWe expect tofinish theMino-Loktrial this yearI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.We willhaveexclusivityWe haveenough cashto go wellinto 2023We will openupinternationalsites forMino-Lok trialI/ONTAKis our leadassetI won't diluteshareholdersWe had aphase 2btrial with100%efficacyInsidersinvested$26.5mMino-Lokpotentialmarket>$1BMino-Lokis our leadasset

Leonard Mazur HCW Conference - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. Not many companies this size with 2 late stage assets
  2. We intend to submit a BLA in 2H 2022
  3. Mino-Wrap
  4. The name Citius comes from the Olympic motto "Citius,Altius Fortius"
  5. An actual iMSC update
  6. Myron Holubiak and I founded a private company in 2013
  7. There are no FDA approved drugs to treat hemorrhoids
  8. Only biotech with 2 Myron's on the leadership team
  9. Our Halo-Lido trial will have final patient by end of 2022
  10. I/ONTAK's potential market is >$300m
  11. Hemorrhoids is a $2B market
  12. I'm a shareholder myself
  13. I/ONTAK was the best deal I ever made
  14. We expect to finish the Mino-Lok trial this year
  15. I/ONTAK was previously approved but taken off the market to improve manufacturing.
  16. We will have exclusivity
  17. We have enough cash to go well into 2023
  18. We will open up international sites for Mino-Lok trial
  19. I/ONTAK is our lead asset
  20. I won't dilute shareholders
  21. We had a phase 2b trial with 100% efficacy
  22. Insiders invested $26.5m
  23. Mino-Lok potential market >$1B
  24. Mino-Lok is our lead asset